33 min listen
The Patient Impact in Drug Development and Value Demonstration with Len Lichtenfeld, MD, MACP
The Patient Impact in Drug Development and Value Demonstration with Len Lichtenfeld, MD, MACP
ratings:
Length:
34 minutes
Released:
Feb 29, 2024
Format:
Podcast episode
Description
Now, more than ever, the patient voice is being heard by the pharmaceutical industry. In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Len Lichtenfeld, MD, MACP meet to discuss the ways patients are providing advisement in drug development and valuation. After hearing about Len’s extensive experience, they delve into the new regulatory changes coming to pharma and biotech that will require the patient experience to be taken into consideration during the drug development process. They conclude by discussing how the patient experience is having an impact on the valuation of new drugs.
Released:
Feb 29, 2024
Format:
Podcast episode
Titles in the series (29)
The Business Objective of Medical Affairs with Holly Schachner, MD: During this episode of Medical Affairs unscripted, Dr. Crowley-Nowick has a conversation with Holly Schachner, MD, former CMO of Specialty Medicine at Allergan to examine the business objective of Medical Affairs (MA) organizations and how MA can move... by Medical Affairs Unscripted